inVentiv Health Launches Fourth Business Segment: inVentiv Patien...( New Segment Combines Capabilities tha...),Health

New Segment Combines Capabilities that Help Patients Achieve Optimum Health

SOMERSET, N.J., Oct. 1 /PRNewswire-FirstCall/ -- inVentiv Health Inc. (Nasdaq: VTIV) today announced that it has launched a fourth business segment, inVentiv Patient Outcomes, with a focus on helping pharmaceutical companies and healthcare payors achieve the best possible medical outcomes for patients.

"When patients get on and stay on the right therapy, everyone wins - the healthcare providers, the pharmaceutical companies, the employers, the healthcare payors, and of course, the patients themselves. Unfortunately, patients often don't stay on therapy long enough or don't achieve the optimum results due to reasons ranging from poor training and education, to inability to afford the treatment, to lack of physician involvement," said Blane Walter, President of inVentiv Health. "With our new Patient Outcomes division, inVentiv is uniquely positioned to address these challenges through an array of services that support better patient care."

The inVentiv Patient Outcomes segment includes:

* The Therapeutics Institute, which is comprised of approximately 300

nurse educators who can assist physicians and nurses in designing and

implementing in-office patient education;

* Adheris, which helps educate and motivate patients to stay on therapy

by providing pharmacy-based communications programs;

* The Franklin Group, which provides access to medication through

reimbursement case management services and administers patient

assistance programs for those who need financial support to afford

their therapy;

* AWAC, inVentiv's newest acquisition, which provides di
'/>"/>